SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Sep-22 6:40 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-22 | Sale | 16,199 | $0.68 | $11,094.70 | (7%) 237.3K to 221.1K | |
04-Apr-22 5:04 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 50,000 | -- | -- | 27% 187.3K to 237.3K | |
07-Jan-22 8:26 PM View: | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-22 | Market Option Sale | 5,133 | $1.25 | $6,416.25 | (3%) 192.43K to 187.3K | |
07-Jan-22 8:26 PM View: | Cidara Therapeutics, Inc. (CDTX) | 29-Dec-21 | Option Exercise | 9,900 | -- | -- | 5% 182.53K to 192.43K | |
04-Oct-21 9:27 PM View: | Cidara Therapeutics, Inc. (CDTX) | 30-Sep-21 | Grant | 132,000 | -- | -- | 261% 50.53K to 182.53K | |
05-Apr-21 6:17 PM View: | Cidara Therapeutics, Inc. (CDTX) | 01-Apr-21 | Market Sale | 593 | $2.66 | $1,577.38 | (1%) 51.12K to 50.53K | |
05-Apr-21 6:17 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-21 | Grant | 1,400 | -- | -- | 3% 49.72K to 51.12K | |
05-Apr-21 6:17 PM View: | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-21 | Market Sale | 2,868 | $2.06 | $5,908.08 | (5%) 52.59K to 49.72K | (31%) |
06-Jan-20 5:26 PM View: | Cidara Therapeutics, Inc. (CDTX) | 03-Jan-20 | Market Sale | 2,340 | $3.42 | $8,002.80 | (4%) 55.87K to 53.53K | 38% |
03-Oct-19 9:15 PM View: | Cidara Therapeutics, Inc. (CDTX) | 02-Oct-19 | Market Sale | 3,295 | $1.88 | $6,194.60 | (6%) 59.17K to 55.87K | (12%) |
16-Sep-19 5:21 PM View: | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-19 | Grant | 9,600 | -- | -- | 19% 49.57K to 59.17K | |
08-Mar-19 7:29 PM View: | Cidara Therapeutics, Inc. (CDTX) | 07-Mar-19 | Market Sale | 2,240 | $2.55 | $5,713.57 | (4%) 51.81K to 49.57K | 18% |
01-Feb-19 7:02 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Jan-19 | Grant | 6,000 | -- | -- | 13% 45.81K to 51.81K | |
19-Sep-17 4:43 PM View: | Cidara Therapeutics, Inc. (CDTX) | 18-Sep-17 | Grant | 15,000 | -- | -- | 49% 30.81K to 45.81K |